Alembic Pharmaceuticals receives EU GMP Certificate for Panelav facility
Following completion of audit conducted from 8 August 2017 to 10 August 2017
Alembic Pharmaceuticals announced that the Company has received EU GMP Certificate for the audit conducted at its Formulation Facility at Panelav from 8 August 2017 to 10 August 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content